Dean Y. Li - Oct 1, 2021 Form 4 Insider Report for RECURSION PHARMACEUTICALS, INC. (RXRX)

Role
Director
Signature
/s/ Nathan Hatfield, attorney-in-fact
Stock symbol
RXRX
Transactions as of
Oct 1, 2021
Transactions value $
$0
Form type
4
Date filed
10/5/2021, 08:24 PM
Previous filing
Jul 6, 2021
Next filing
Dec 9, 2021

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction RXRX Class A Common Stock Award $0 +543 +0.09% $0.00 597K Oct 1, 2021 Direct F1
holding RXRX Class A Common Stock 1.42M Oct 1, 2021 By Dean Li and Ruth Li Revocable Trust
holding RXRX Class A Common Stock 450K Oct 1, 2021 By Dean Y. Li 2021 2021 Family Trust
holding RXRX Class A Common Stock 1.35M Oct 1, 2021 By Dean Y. Li 2021 2021 GRAT
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The shares were issued pursuant to the Issuer's Outside Director Compensation Policy.